Skip to main content
Tech.euFundingExplorerBeta

Neurent Medical

the company behind NEUROMARK, a minimally invasive solution to treat chronic rhinitis

Neurent Medical has raised €84M across 2 funding rounds from 8 investors, most recently a round in Sep 2026. Based in Galway, Ireland; active in Healthtech. Data as of 28 Oct 2026.

Total raised
€84M
€83,955,544
Funding rounds
2
Investors
8
distinct backers
Active since
2026-02
latest 2026-09

Funding by year

EUR raised per year · 2026 YTD
Neurent Medical — funding by year — interactive chart.
Data table
Neurent Medical — funding by year
2026€84M

Signals

High confidence
Raise-next likelihood12
base rate 30% for Other
  • ▼ Raised very recently
  • ▼ Down/flat last round
Exit likelihood18
base rate 11% (2+ rounds)
  • ▲ €30M+ raised
  • ▼ Young (<3y)
  • ▲ Recent equity round, but funding momentum is down (may be rescue financing)

Timing: too soon vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

2 rounds
DateStageAmountInvestors
2026-09-09Other€21MClaret Capital PartnersView deal →
2026-02-13Series C€63MAtlantic Bridge,Enterprise Ireland,EQT Life Sciences,Existing investors,Fountain Healthcare Partners,MVM Partners+1 moreView deal →

Similar companies

same sector or country

Global coverage: FundingData